Change of administration route of allergen immunotherapy: Rates and causes

Main Article Content

Cristina Rivas-Juesas
Paediatrics Department, Sagunto Hospital, Port de Sagunt, Valencia, Spain.
https://orcid.org/0000-0001-5396-7424
Ana Delgado Vicente
Paediatrics Department, Sagunto Hospital, Port de Sagunt, Valencia, Spain.

Keywords

allergen immunotherapy, administration route, subcutaneous immunotherapy, sublingual immunotherapy, treatment adherence, respiratory allergy

Abstract

Allergen immunotherapy (AIT) has shown efficacy in the short and the long term in the management of allergic respiratory diseases, and it’s administered subcutaneously (subcutaneous immunotherapy, or SCIT) or sublingually (sublingual immunotherapy, or SLIT), being both effective and safe options.

Abstract 115 | PDF Downloads 180 HTML Downloads 0 XML Downloads 5

References

1 Yang J and Lei S. Efficacy and safety of sublingual versus subcutaneous immunotherapy in children with allergic rhinitis: A systematic review and meta-analysis. Front. Immunol. 2023 Dec 15;14:1274241. 10.3389/fimmu.2023.1274241

2 Muraro A, Roberts G, Halken S, Agache I, Angier E, Fernandez-Rivas M, et al. EAACI guidelines on allergen immunotherapy: Executive statement. Allergy [Internet]. 2018 Apr 1 [cited 2024 Mar 11];73(4):739–43. 10.1111/all.13420

3 Gehrt F, Xu Q, Baiardini I, Canonica GW, Pfaar O. Adherence in allergen immunotherapy: Current situation and future implications. Allergol. Sel. [Internet]. 2022 Dec 1 [cited 2024 Mar 11];6(12):876–84. Available from: 10.5414/ALX02318E

4 Senna G, Caminati M, Lockey RF. Allergen immunotherapy adherence in the real world: How bad is it and how can it be improved? Curr. Treat. Options Allergy [Internet]. 2015 Mar 1 [cited 2024 Mar 11];2(1):39–53. 10.1007/s40521-014-0037-6

5 Baiardini I, Novakova S, Mihaicuta S, Oguzulgen IK, Canonica GW. Adherence to treatment in allergic respiratory diseases. Expert Rev. Respir. Med. [Internet]. 2019 Jan 2 [cited 2024 Mar 11];13(1):53–62. 10.1080/17476348.2019.1554438

6 Pfaar O, Devillier P, Schmitt J, Demoly P, Hilberg O, DuBuske L, et al. Adherence and persistence in allergen immunotherapy (APAIT): A reporting checklist for retrospective studies. Allergy [Internet]. 2023 Aug 1 [cited 2024 Mar 11];78(8):2277–89. 10.1111/all.15723

7 Vogelberg C, Brüggenjürgen B, Richter H, Jutel M. Real-world adherence and evidence of subcutaneous and sublingual immunotherapy in grass and tree pollen-induced allergic rhinitis and asthma. Patient Prefer Adherence [Internet]. 2020 [cited 2024 Mar 11];14:817–27. 10.2147/PPA.S242957

8 Liu W, Zeng Q, He C, Chen R, Tang Y, Yan S, et al. Compliance, efficacy, and safety of subcutaneous and sublingual immunotherapy in children with allergic rhinitis. Pediatr. Allergy Immunol. [Internet]. 2021 Jan 1 [cited 2024 Mar 11];32(1):86–91. 10.1111/pai.13332

Article Sidebar

PDF HTML XML
Published
Mar 1, 2025
DOI: https://doi.org/10.15586/aei.v53i2.1196

Article Details

How to Cite
Rivas-Juesas, C., & Delgado Vicente, A. (2025). Change of administration route of allergen immunotherapy: Rates and causes. Allergologia Et Immunopathologia, 53(2), 10-12. https://doi.org/10.15586/aei.v53i2.1196
Issue
Vol. 53 No. 2 (2025): Allergologia et immunopathologia
Section
Research Letter

How to Cite

Rivas-Juesas, C., & Delgado Vicente, A. (2025). Change of administration route of allergen immunotherapy: Rates and causes. Allergologia Et Immunopathologia, 53(2), 10-12. https://doi.org/10.15586/aei.v53i2.1196